FDA Publishes Guidance on Suspect Product Identification and Notification
The FDA has just published DSCSA industry guidance for the identification of suspect product and notification. This document is currently available and outlines the following:
- Scenarios that increase the risk of potential suspect product entering the supply chain.
- Recommendations on how to identify suspect product.
- Notification procedures for products that are illegitimate or have a high risk of illegitimacy.
- Termination of notification procedures.
You can review this 17-page report directly from the FDA website.